References

pharmjournal

Разработка и регистрация лекарственных средств

Drug development & registration

2305-20662658-5049

LLC «CPHA»

pharmjournal-291

Research Article

ФАРМАЦЕВТИЧЕСКАЯ ТЕХНОЛОГИЯ И НАНОТЕХНОЛОГИИ

PHARMACEUTICAL TECHNOLOGY AND NANOTECHNOLOGY

ЦИКЛОДЕКСТРИНЫ И ИХ ПРИМЕНЕНИЕ В ФАРМАЦЕВТИЧЕСКОЙ ПРОМЫШЛЕННОСТИ (ОБЗОР)

CYCLODEXTRINS AND THEIR APPLICATION IN PHARMACEUTICAL INDUSTRY (REVIEW)

Кедик

С. А.

Kedik

S. A.

noemail@neicon.ru

Панов

А. В.

Panov

A. V.

noemail@neicon.ru

Тюкова

В. С.

Tyukova

V. S.

noemail@neicon.ru

Золотарева

М. С.

Zolotareva

M. S.

noemail@neicon.ru

Московский технологический университет (МИТХТ)Moscow Technological University (MITHT)

2016

09012019

036875

2019

Кедик С.А., Панов А.В., Тюкова В.С., Золотарева М.С.

Kedik S.A., Panov A.V., Tyukova V.S., Zolotareva M.S.

Данная работа распространяется под лицензией Creative Commons Attribution 4.0.

This work is licensed under a Creative Commons Attribution 4.0 License.

https://www.pharmjournal.ru/jour/article/view/291

В обзоре литературы рассмотрены основные свойства циклодекстринов и возможность их использования в рецептурах раз личных лекарственных форм в качестве вспомогательных веществ, благодаря которым становится возможным увеличение растворимости лекарственных веществ, биодоступности и стабильности лекарственного препарата.

In the review describes the main properties of cyclodextrins and their potential use in the formulations in various dosage forms as excipients, by which it becomes possible to modify the solubility of drugs, increase the bioavailability and stability of the drug.

цик лодекстриныкомплекс вк лючениярастворимостьбиодост упность

cyclodextrinsinclusion complexsolubilitybioavailability

References1

А.В. Душкин, Л.П. Сунцова, С.С. Халиков. Механохимическая технология растворимости лекарственных веществ // Pharmaceutical sciences. 2013. № 1. С. 448-457.

T. Loftsson, D. Duchene, Cyclodextrins and their applications // International Journal of Pharmaceutics. 2007. № 329. P. 1-11.

H. Dodziuk. Cyclodextrins and their complexes. - Wheinheim: Wiley-VCH Verlag, 2006. 489 p.

Н.Г. Гулюк, Т.С. Пучкова, Д.М. Пихало, В.А. Гулакова. Исследование кинетики кислотного и ферментативного гидролиза циклодекстринов // Пищевая и перерабатывающая промышленность. 2010. № 12. С. 67.

E.M. Martin Del Valle. Cyclodextrins and their uses: a review // Process Biochemistry. 2004. № 39. P. 1033-1046.

О.А. Иноземцева. Физико-химические свойства монослоев и пленок Ленгмюра - Блоджетт силилированных бромсодержащих производных β-циклодекстрина: дис. … к. хим. н. - Саратов: СГУ, 2006. 151 с.

G. Castronuovo, M. Niccoli, Thermodynamics of inclusion complexes of natural and modified cyclodextrins with acetylsalicylic acid and ibuprofen in aqueous solution at 298 K // Thermochimica Acta. 2013. № 557. P. 44-49.

C. Krzysztof, K. Centkowska. Use of cyclodextrins in topical formulations: Practical aspects // European Journal of Pharmaceutical and Biopharmaceutics. 2008. № 68. P. 467-478.

K. Hussein, M. Turk, M.A. Wahl. Comparative Evaluation of Ibuprofen/β-Cyclodextrin Complexes Obtained by Supercritical Carbon Dioxide and Other Conventional Methods // Pharmaceutical Research. 2007. V. 24. № 3. P. 585-592.

A. Bounaceur, E. Rodier. Study of the maturation of a Ketoprofen/β-cyclodextrin complex // Journal of Pharmaceutical Science and Technology. 2010. V. 2(3). P.171-183.

S.R.S. Rudrangi, W. Kaialy, M.U. Ghori, V. Trivedi, M.J. Snowden, B.D. Alexander. Solid-state flurbiprofen and methyl-β-cyclodextrin inclusion complexes prepared using a single-step, organic solvent-free supercritical fluid process // European Journal of Pharmaceutics and Biopharmaceutics. 2016. V. 104. P. 164-170. URL: http://dx.doi.org/10.1016/j.ejpb.2016.04.024 (дата обращения 15.07.2016).

Патент US 4228160 A. Inclusion complex of cyclodextrin and Indomethacin and a process for the preparation thereof, method of use and pharmaceutical composition / L.J. Penkler, M.D. Bodley. - № 95/001152; filing 22.05.95; publ. 07.12.95.

Патент US № 5472954 A. Cyclodextrin complexation / T. Loftsson. - № 07/912853; filing 07.14.1992; publ. 06.28.1994.

H. Yano, F. Hirayama, M. Kamada, H. Arima, K. Uekama. Colon-specific delivery of prednisolone-appended a-cyclodextrin conjugate: alleviation of systemic side effect after oral administration // J. Cont. Rel. 2002. V. 79. № 1-3. P. 103-112.

Патент US № 6699849. Cyclodextrin complexes of benzodiazepines / T. Loftsson, M. Masson, E. Stefansson. - № 09/250185; filing 02.16.1999; publ. 03.02.2004.

I. Kacso, G. Borodi, S. I. Farcas, I. Bratu. Inclusion compound of vitamin B13 in b-Cyclodextrin // J. Phys.: Conference Series. 2009. V. 182. P. 1-5.

K. Uekama, T. Fujinaga, F. Hirayama. Improvement of the oral bioavailability of digitalis glycosides by cyclodextrin complexation // Pharmaceutical Science. 1983. № 72. P. 1338-1341.

Y. Nakai, K. Yamamoto, K. Terada. Interaction of tri-O-methyl-β-cyclodextrin with drugs // J. Incl. Phenom. 1984. № 2. P. 523-531.

J.J. Berzas Nevado, J.A. Murillo Pulgarin, M.A. Gomez Laguna. Spectrofluorometric study of the β-cyclodextrin: vitamin K3 complex and determination of vitamin K3 // Talanta. 2001. № 53. P. 951-959.

L.A. Belyakova, A.M. Varvarin, D.Yu. Lyashenko, O.V. Khora, E.I. Oranskaya. Complexation in a β-cyclodextrin-salicylic acid system // Colloid Journal. 2007. V. 69. № 5. P. 546-551.

K. Uekama, M. Otagiri, K Tasaki, A. Sugii. Improvement of oral bioavailability of Prednizalone by β-cyclodextrin complexation in humans // J. Pharm. Dyn. 1993. № 6. P. 124-127.

T. Vila-Jato, J. Blanco. Spirolactone/β-cyclodextrine complex: oral bioavailability in humans // Acta Pharmaceutical Technology. 1998. № 32. P. 82-85.

K. Uekama, K. Udo, T. Irie. Improvement of dissolution and absorption characteristics of indomethacin by water soluble α-cyclodextrine-epichlorohydrin polymer // Acta Pharm. Suec. 1987. № 24. P. 27-36.

J. Pitha, S.M. Harmau, M.E. Michel. Hydrophilic cyclodextrin derivates enable effective oral administration of steroidal hormones // J. Pharm. Sci. 1996. № 75. P. 165-167.

H. Beraldo, R.D. Sinisterra, L.R. Vieira, M.C. Doretto. An effective anticonvulsant prepared following a host-guest strategy that uses hydroxypropyl-beta-cyclodextrin and benzaldehyde semicarbazone // Biochem Biophys Res Commun. 2002. № 296. P. 241-246.

K. Nishimura, R. Hidaka, F. Hirayama, H. Arima, K. Uekama. Improvement of dispersion and release properties of nifedipine in suppositories by complexation with 2-hydroxypropyl-β-cyclodextrin // Journal of Inclusion Phenomena and Macrocyclic Chemistry. 2006. № 56. P. 85-88.

M. Otagirri, T. Imai. Improvements to some pharmaceutical properties of flurbiprofen by β- and γ-cyclodextrin complexations // Acta Pharm. Suec. 1993. № 20. P. 1-10.

K. Kikuchi, F. Hirayama. Improvement of oral and rectal bioavailabilities of carmofur by methylated-β- cyclodextrin complexation // International Journal of Pharmaceutics. 1997. № 39. P. 191-198.

L. Szente, I. Apostol, J. Szejtli. Suppositories containing cyclodextrin complexes // Pharmazie. 1995. № 40. P. 406-407.

B. Malaekeh-Nikouei, S.A.S. Tabassi, G. Gerayeli, M.A. Salmani, A. Gholamzadeh. The effect of cyclodextrin mixtures on aqueous solubility of beclomethasone dipropionate // Journal of Inclusion Phenomena and Macrocyclic Chemistry. 2012. V. 72. I. 3. P. 383-387.

R. Challa, A. Ahuja, J. Ali. Cyclodextrins in drug delivery: an update review // Pharmaceutical Science Technology. 2005. V. 6. № 2. P. 329-357.

T. Loftsson, D. Duchêneb. Cyclodextrins and their pharmaceutical applications // International Journal of Pharmaceutics. 2007. V. 329. I. 1-2. P. 1-11.

А.В. Астахова, Н.Б. Демина. Современные технологии лекарственных форм: получение, исследование и применение комплексов включения лекарственных веществ с циклодекстринами (обзор) // Химико-фармацевтический журнал. 2004. Т. 38. № 2. С. 46-49.

S.V. Kurkov, D.E. Madden, D. Carr, T. Loftsson. The Effect of Parenterally Administered Cyclodextrins on the Pharmacokinetics of Coadministered Drugs // Journal of Pharmaceutical Sciences. 2012. V. 101. Issue 12. P. 4367-4668.

S. Baboota, R. Khanna, S.P. Agarwal. Cyclodextrins in Drug Delivery Systems: An update // Pharmaceutical Information. 2003. № 58. Р. 73-74.

W. Leng, L. Qin, X. Tang. Chitosan and Randomly Methylated β-cyclodextrin Combined to Enhance the Absorption and Elevate the Bioavailability of Estradiol Intranasally: in situ and in vivo Studies // The Journal of American Science. 2006. V. 2(1). P. 61-66.

M.E. Brewster, T. Loftsson. Cyclodextrins as pharmaceutical solubilizers // Advanced Drug Delivery Reviews. 2007. V. 59. I. 7. P. 645-666.

E. Stefánsson, T. Loftsson. Cyclodextrins in eye drop formulations // Journal Incl. Phenom. Macroc. Chem. 2002. № 44. P. 23-27.

T. Loftsson, P. Jarho, M. Másson, T. Järvinen. Cyclodextrins in drug delivery // Expert Opinion on Drug Delivery. 2005. V. 2. I. 2. P. 335-351.

T. Loftsson, S.D. Sigfússon, H.H. Sigurðsson, M. Másson. The effects of cyclodextrins on topical delivery of hydrocortisone: the aqueous diffusion layer // STP Pharma Sci. 2003. № 13. P. 125-131.

K. Ravindra Reddy, M. Ravi Shankar Yadav, P. Sabitha Reddy. Preparation and evaluation of Aceclofenac ophthalmic in-situ gels // Journal of Chemical, Biological and Physical Sciences. 2011. V. 1. № 2. P. 289-298.

E. Stefansson, S. Thorisdottir, O.G. Gudmundsson, T. Loftsson, H. Fridriksdottir, J.K. Kristinsson. HPβCD in eye drops: evaluation of artificial tear-drops in human patients // Proceedings of the 8th International Cyclodextrins Symposium (J. Szejtli and L. Szente, Eds.). - Dordrecht: Kluwer Academic Publishers. 1996. P. 391-394.

M. Masson, T. Loftsson, H. Fridriksdottir, D.S. Petersen. Complexation of drug compounds with ionic and ionic cyclodextrins // Proceedings of the 8th International Cyclodextrins Symposium (J. Szejtli and L. Szente, Eds.). - Dordrecht: Kluwer Academic Publishers. 1996. P. 365-368.

A.R. Bary, I.G. Tucker, N.M. Davies. Considerations in the use of hydroxypropyl-beta-cyclodextrin in the formulation of aqueous ophthalmic solutions of hydrocortisone // Eur. J. Pharm Biopharm. 2000. V. 50(2). P. 237-244.

T. Loftsson, E. Stefansson. Cyclodextrin enhanced topical delivery of corticosteroids to the eye // Acta Ophthalmol. Scand. 2002. № 80. P. 144-150.

E. Gudmundsdottir, E. Stefansson, G. Bjarnadottir, J.F. Sigurjonsdottir, G. Gudmundsdottir, M. Masson, T. Loftsson. Methazolamide 1% in cyclodextrin solution lowers IOP in ocular hypertensive humans // Inv. Ophthalmol. Vis. Sci. 2000. V. 41(11). P. 3552-3554.

N. Nagai, Y. Ito, N. Okamoto. Preparation of ophthalmic formulations containing cilostazol as an antiglaukoma agent and improvement in its permeability through the rabbit cornea // J. Oleo Science. 2010. V. 59(8). P. 423-430.

A. Bozkir, Z. Denli. Effect of hydroxypropil-β-cyclpdextrin on the solubility, stability and in vitro release of ciprofloxacin for ocular drug delivery // Acta Poloniae Pharmaceutica - Drug research. 2012. V. 69 (4). P. 719-724.

T. Jansen, B. Xhonneux, J. Mesens, M. Borgers. Betacyclodextrins as vehicles in eye-drop formulation: an evaluation of their effects on rabbit corneal epiteliumn // Lens Eye Toxicity Res. 1990. № 7. P. 459-468.

N. Nagai, Y. Ito, N. Takeuchi, Pharmacokinetic and Pharmacodynamic evalution of the anti-cataract effect of drops containing Disulfiram and lowsubstituted methylcellulose using ICR/f rats as a hereditary cataract model // Biol. Pharm. Bull. 2012. V. 35(2). P. 239-245.

Патент РФ № 2485939. Офтальмологический препарат в виде глазных капель, содержащий дисульфирам и таурин / С.А. Кедик, Е.И. Ярцев, А.В. Панов, В.В. Суслов, И.В. Сакаева. - № 2012125357/15; заявл. 19.06.2012; опубл. 27.06.2013.

The authors declare that there are no conflicts of interest present.